semaglutide and neuropathy Wegovy may raise risk of ischemic optic ποΈ The obesity drug semaglutide, marketed as Wegovy, was associated with a significantly higher risk of ischemic optic neuropathy than the diabetes formulation Ozempic Comparative safety and side effects
Description
Vital Health Stat 1
What to do : These symptoms are usually mild and go away on their own
Do my labs show prediabetes or type 2 diabetes
If you extend the interval to every other week, the medication level in your body drops significantly between injections
Clinical trial data show comparable cardiovascular and kidney protection between medications
